nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
|
Brestrich, G. |
|
|
9 |
7 |
p. 1679-1684 |
artikel |
2 |
Balancing Multiple and Conflicting Allocation Goals: A Logical Path Forward
|
Stock, P.G. |
|
|
9 |
7 |
p. 1519-1522 |
artikel |
3 |
Deceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to Rhabdomyolysis
|
Mekeel, K.L. |
|
|
9 |
7 |
p. 1666-1670 |
artikel |
4 |
Delay of Adequate Empiric Antibiotic Therapy Is Associated with Increased Mortality among Solid-Organ Transplant Patients
|
Hamandi, B. |
|
|
9 |
7 |
p. 1657-1665 |
artikel |
5 |
Developing a New Kidney Allocation Policy: The Rationale for Including Life Years from Transplant
|
Winters, M.D. |
|
|
9 |
7 |
p. 1528-1532 |
artikel |
6 |
Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort Study
|
Titman, A. |
|
|
9 |
7 |
p. 1640-1649 |
artikel |
7 |
Early Renal Ischemia-Reperfusion Injury in Humans Is Dominated by IL-6 Release from the Allograft
|
de Vries, D.K. |
|
|
9 |
7 |
p. 1574-1584 |
artikel |
8 |
Erratum
|
|
|
|
9 |
7 |
p. 1698 |
artikel |
9 |
Evaluating Options for Utility-Based Kidney Allocation
|
Segev, D.L. |
|
|
9 |
7 |
p. 1513-1518 |
artikel |
10 |
Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial
|
Gaston, R.S. |
|
|
9 |
7 |
p. 1607-1619 |
artikel |
11 |
Heavy LYFTing: KASting Pearls Before Swine
|
Bromberg, J. |
|
|
9 |
7 |
p. 1489-1490 |
artikel |
12 |
Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation
|
Ramirez, S. |
|
|
9 |
7 |
p. 1591-1601 |
artikel |
13 |
HLA-C and Liver Transplant Outcomes: Interpreting the Facts
|
Mendel, J.B. |
|
|
9 |
7 |
p. 1491-1492 |
artikel |
14 |
Ischemic Preconditioning (IP) of the Liver as a Safe and Protective Technique against Ischemia/Reperfusion Injury (IRI)
|
Franchello, A. |
|
|
9 |
7 |
p. 1629-1639 |
artikel |
15 |
Life Insurance for Living Kidney Donors: A Canadian Undercover Investigation
|
Yang, R.C. |
|
|
9 |
7 |
p. 1585-1590 |
artikel |
16 |
Lung Transplantation Outcomes: The Importance and Inadequacies of Assessing Survival
|
Yusen, R.D. |
|
|
9 |
7 |
p. 1493-1494 |
artikel |
17 |
Moving Kidney Allocation Forward: The ASTS Perspective
|
Freeman, R.B. |
|
|
9 |
7 |
p. 1501-1506 |
artikel |
18 |
Mycophenolate Blood Level Monitoring: Recent Progress
|
van Gelder, T. |
|
|
9 |
7 |
p. 1495-1499 |
artikel |
19 |
News and issues that affect organ and tissue transplantation
|
PONDROM, SUE |
|
|
9 |
7 |
p. 1487-1488 |
artikel |
20 |
Orthotopic, but Reversed Implantation of the Liver Allograft in SitusInversus Totalis—A Simple New Approach to a Difficult Problem
|
Rayhill, S.C. |
|
|
9 |
7 |
p. 1602-1606 |
artikel |
21 |
Predictability of Survival Models for Waiting List and Transplant Patients: Calculating LYFT
|
Wolfe, R.A. |
|
|
9 |
7 |
p. 1523-1527 |
artikel |
22 |
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients
|
Potenza, L. |
|
|
9 |
7 |
p. 1690-1697 |
artikel |
23 |
Proton Pump Inhibitors Reduce Mycophenolate Exposure in Heart Transplant Recipients-A Prospective Case-Controlled Study
|
Kofler, S. |
|
|
9 |
7 |
p. 1650-1656 |
artikel |
24 |
Reassessing the Impact of Donor HLA-C Genotype on Long-Term Liver Transplant Survival
|
Tran, T.H. |
|
|
9 |
7 |
p. 1674-1678 |
artikel |
25 |
Recipient Outcomes for Expanded Criteria Living Kidney Donors: The Disconnect Between Current Evidence and Practice
|
lordanous, Y. |
|
|
9 |
7 |
p. 1558-1573 |
artikel |
26 |
Rejection Reversibly Alters Enteroendocrine Cell Renewal in the Transplanted Small Intestine
|
Fishbein, T.M. |
|
|
9 |
7 |
p. 1620-1628 |
artikel |
27 |
Secondary Listing for Deceased-Donor Kidney Transplantation Does Not Increase Likelihood of Engraftment at a Large Transplant Center
|
Kumar, V. |
|
|
9 |
7 |
p. 1671-1673 |
artikel |
28 |
The AST’s Perspective on the Proposed Kidney Allocation System
|
Murphy, B. |
|
|
9 |
7 |
p. 1500 |
artikel |
29 |
The Effects of DonorNet 2007 on Kidney Distribution Equity and Efficiency
|
Massie, A.B. |
|
|
9 |
7 |
p. 1550-1557 |
artikel |
30 |
The Kidney Allocation Score: Methodological Problems, Moral Concerns and Unintended Consequences
|
Hippen, B. |
|
|
9 |
7 |
p. 1507-1512 |
artikel |
31 |
The Pregnancy Rate and Live Birth Rate in Kidney Transplant Recipients
|
Gill, J.S. |
|
|
9 |
7 |
p. 1541-1549 |
artikel |
32 |
Tirofiban and Activated Protein C Synergistically Inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from Allogeneic Islet Cells Exposure to Human Blood
|
Akima, S. |
|
|
9 |
7 |
p. 1533-1540 |
artikel |
33 |
Unrecognized Acute Phosphate Nephropathy in a Kidney Donor with Consequent Poor Allograft Outcome
|
Agrawal, N. |
|
|
9 |
7 |
p. 1685-1689 |
artikel |